. The company’s pipeline includes four scientific-stage therapies. Its most Innovative drug prospect is ROS1 inhibitor taletrectinib for treating lung cancer. Nuvation is finishing two phase 2 pivotal studies on taletrectinib. The list of symbols integrated to the web site is updated each ten minutes all over the trading https://financefeeds.com/bnb-technical-analysis-report-8-april-2025/